Suppr超能文献

中国健康码应用程序的个人信息保护和隐私政策合规性:量表开发与内容分析。

Personal Information Protection and Privacy Policy Compliance of Health Code Apps in China: Scale Development and Content Analysis.

机构信息

Law School, Central South University, Changsha, China.

出版信息

JMIR Mhealth Uhealth. 2023 Nov 14;11:e48714. doi: 10.2196/48714.

Abstract

BACKGROUND

Digital technologies, especially contact tracing apps, have been crucial in monitoring and tracing the transmission of COVID-19 worldwide. China developed health code apps as an emergency response to the pandemic with plans to use them for broader public health services. However, potential problems within privacy policies may compromise personal information (PI) protection.

OBJECTIVE

We aimed to evaluate the compliance of the privacy policies of 30 health code apps in the mainland of China with the Personal Information Protection Law (PIPL) and related specifications.

METHODS

We reviewed and assessed the privacy policies of 30 health code apps between August 26 and September 6, 2023. We used a 3-level indicator scale based on the information life cycle as provided in the PIPL and related specifications. The scale comprised 7 level-1 indicators, 26 level-2 indicators, and 71 level-3 indicators.

RESULTS

The mean compliance score of the 30 health code apps was 59.9% (SD 22.6%). A total of 13 (43.3%) apps scored below this average, and 6 apps scored below 40%. Level-1 indicator scores included the following: general attributes (mean 85.6%, SD 23.3%); PI collection and use (mean 66.2%, SD 22.7%); PI storage and protection (mean 63.3%, SD 30.8%); PI sharing, transfer, disclosure, and transmission (mean 57.2%, SD 27.3%); PI deletion (mean 52.2%, SD 29.4%); individual rights (mean 59.3%, SD 25.7%); and PI processor duties (mean 43.7%, SD 23.8%). Sensitive PI protection compliance (mean 51.4%, SD 26.0%) lagged behind general PI protection (mean 83.3%, SD 24.3%), with only 1 app requiring separate consent for sensitive PI processing. Additionally, 46.7% (n=14) of the apps needed separate consent for subcontracting activities, while fewer disclosed PI recipient information (n=13, 43.3%), safety precautions (n=11, 36.7%), and rules of PI transfer during specific events (n=10, 33.3%). Most privacy policies specified the PI retention period (n=23, 76.7%) and postperiod deletion or anonymization (n=22, 73.3%), but only 6.7% (n=2) were committed to prompt third-party PI deletion. Most apps delineated various individual rights: the right to inquire (n=25, 83.3%), correct (n=24, 80%), and delete PI (n=24, 80%); cancel their account (n=21, 70%); withdraw consent (n=20, 60%); and request privacy policy explanations (n=24, 80%). Only a fraction addressed the rights to obtain copies (n=4, 13.3%) or refuse advertisement of automated decision-making (n=1, 3.3%). The mean compliance rate of PI processor duties was only 43.7% (SD 23.8%), with significant deficiencies in impact assessments (mean 5.0%, SD 19.8%), PI protection officer appointment (mean 6.7%, SD 24.9%), regular compliance audits (mean 6.7%, SD 24.9%), and complaint management (mean 37.8%, SD 39.2%).

CONCLUSIONS

Our analysis revealed both strengths and significant shortcomings in the compliance of privacy policies of health code apps with the PIPL and related specifications considering the information life cycle. As China contemplates the future extended use of health code apps, it should articulate the legitimacy of the apps' normalization and ensure that users provide informed consent. Meanwhile, China should raise the compliance level of relevant privacy policies and fortify its enforcement mechanisms.

摘要

背景

数字技术,特别是接触者追踪应用程序,在全球范围内监测和追踪 COVID-19 的传播方面发挥了至关重要的作用。中国开发了健康码应用程序作为对大流行的紧急响应,计划将其用于更广泛的公共卫生服务。然而,隐私政策中的潜在问题可能会危及个人信息(PI)保护。

目的

我们旨在评估中国大陆 30 个健康码应用程序的隐私政策遵守《个人信息保护法》(PIPL)和相关规范的情况。

方法

我们在 2023 年 8 月 26 日至 9 月 6 日期间审查并评估了 30 个健康码应用程序的隐私政策。我们使用了 PIPL 和相关规范中提供的基于信息生命周期的 3 级指标量表。该量表包括 7 个一级指标、26 个二级指标和 71 个三级指标。

结果

30 个健康码应用程序的平均合规分数为 59.9%(SD 22.6%)。共有 13 个(43.3%)应用程序的得分低于该平均值,6 个应用程序的得分低于 40%。一级指标得分包括:一般属性(平均 85.6%,SD 23.3%);PI 收集和使用(平均 66.2%,SD 22.7%);PI 存储和保护(平均 63.3%,SD 30.8%);PI 共享、转移、披露和传输(平均 57.2%,SD 27.3%);PI 删除(平均 52.2%,SD 29.4%);个人权利(平均 59.3%,SD 25.7%)和 PI 处理器职责(平均 43.7%,SD 23.8%)。敏感 PI 保护合规性(平均 51.4%,SD 26.0%)落后于一般 PI 保护(平均 83.3%,SD 24.3%),只有 1 个应用程序需要对敏感 PI 处理进行单独同意。此外,46.7%(n=14)的应用程序需要对分包活动进行单独同意,而披露 PI 接收方信息的应用程序较少(n=13,43.3%)、安全措施(n=11,36.7%)和特定事件期间 PI 转移规则(n=10,33.3%)。大多数隐私政策指定了 PI 保留期限(n=23,76.7%)和后期限删除或匿名化(n=22,73.3%),但只有 6.7%(n=2)承诺及时删除第三方 PI。大多数应用程序规定了各种个人权利:查询权(n=25,83.3%)、更正权(n=24,80%)和删除 PI 权(n=24,80%);取消其账户(n=21,70%);撤回同意权(n=20,60%);请求隐私政策解释权(n=24,80%)。只有一小部分涉及获取副本的权利(n=4,13.3%)或拒绝自动决策的广告(n=1,3.3%)。PI 处理器职责的合规率仅为 43.7%(SD 23.8%),在影响评估(平均 5.0%,SD 19.8%)、PI 保护官员任命(平均 6.7%,SD 24.9%)、定期合规审计(平均 6.7%,SD 24.9%)和投诉管理(平均 37.8%,SD 39.2%)方面存在显著缺陷。

结论

我们的分析表明,考虑到信息生命周期,健康码应用程序的隐私政策在遵守 PIPL 和相关规范方面存在强弱参半的情况。随着中国考虑未来扩大健康码应用程序的使用,应该阐明应用程序正常化的合法性,并确保用户提供知情同意。同时,中国应该提高相关隐私政策的合规水平,并加强其执行机制。

相似文献

7
Smartphone and tablet self management apps for asthma.用于哮喘的智能手机和平板电脑自我管理应用程序。
Cochrane Database Syst Rev. 2013 Nov 27;2013(11):CD010013. doi: 10.1002/14651858.CD010013.pub2.

本文引用的文献

1
Lessons on mobile apps for COVID-19 from China.来自中国的新冠疫情移动应用经验教训。
J Saf Sci Resil. 2021 Jun;2(2):40-49. doi: 10.1016/j.jnlssr.2021.04.002. Epub 2021 May 13.
8
COVID-19 and Health Code: How Digital Platforms Tackle the Pandemic in China.新冠疫情与健康码:数字平台如何在中国应对疫情
Soc Media Soc. 2020 Aug 11;6(3):2056305120947657. doi: 10.1177/2056305120947657. eCollection 2020 Jul.

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验